Minerva Neurosciences, Inc. (NERV)
6.31
-0.03
(-0.47%)
USD |
NASDAQ |
Feb 20, 16:00
6.39
+0.08
(+1.27%)
After-Hours: 20:00
Minerva Neurosciences Total Assets (Quarterly) : 28.09M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 140.92M |
| BioMarin Pharmaceutical, Inc. | 7.615B |
| Imunon, Inc. | 8.988M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 62.67M |
| Shareholders Equity (Quarterly) | -34.58M |
| Debt to Equity Ratio | -1.735 |
| Current Ratio | 4.872 |
| Net Debt Paydown Yield | 36.11% |